Literature DB >> 24255781

Chinese guideline for the prevention and management of bronchial asthma (Primary Health Care Version).

.   

Abstract

Entities:  

Year:  2013        PMID： 24255781      PMCID： PMC3815723          DOI： 10.3978/j.issn.2072-1439.2013.10.16

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  9 in total

1.  Changes of serum TNF-α, IL-5 and IgE levels in the patients of mycoplasma pneumonia infection with or without bronchial asthma.

Authors:  Lan Wang; Qiang Chen; Cuiqin Shi; Hanjing Lv; Xianghuai Xu; Li Yu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  The upregulated expression of OX40/OX40L and their promotion of T cells proliferation in the murine model of asthma.

Authors:  Wei Lei; Da-Xiong Zeng; Can-Hong Zhu; Gao-Qin Liu; Xiu-Qin Zhang; Chang-Guo Wang; Qin Wang; Jian-An Huang
Journal:  J Thorac Dis       Date:  2014-07       Impact factor: 2.895

3.  Efficacy of acupuncture for chronic asthma: study protocol for a randomized controlled trial.

Authors:  Lei-Miao Yin; Yu Wang; Lei Fan; Yu-Dong Xu; Wen-Qian Wang; Yan-Yan Liu; Jun-Tao Feng; Cheng-Ping Hu; Pei-Yu Wang; Tie-Feng Zhang; Su-Ju Shao; Yong-Qing Yang
Journal:  Trials       Date:  2015-09-23       Impact factor: 2.279

4.  Physician perspectives on the burden and management of asthma in six countries: The Global Asthma Physician Survey (GAPS).

Authors:  Kenneth R Chapman; David Hinds; Peter Piazza; Chantal Raherison; Michael Gibbs; Timm Greulich; Kenneth Gaalswyk; Jiangtao Lin; Mitsuru Adachi; Kourtney J Davis
Journal:  BMC Pulm Med       Date:  2017-11-23       Impact factor: 3.317

Review 5.  Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition).

Authors:  Yongchun Shen; Shaoguang Huang; Jian Kang; Jiangtao Lin; Kefang Lai; Yongchang Sun; Wei Xiao; Lan Yang; Wanzhen Yao; Shaoxi Cai; Kewu Huang; Fuqiang Wen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-30

6.  Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian population.

Authors:  Hironori Sagara; Nathalie Barbier; Tsuyoshi Ishii; Hajime Yoshisue; Ivan Nikolaev; Motoi Hosoe; Yasuhiro Gon
Journal:  BMJ Open Respir Res       Date:  2021-03

7.  A comprehensive analysis of microRNAs as diagnostic biomarkers for asthma.

Authors:  Li Xu; Minhan Yi; Yun Tan; Zixun Yi; Yuan Zhang
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

8.  Irrational Use of Medicine in the Treatment of Presumptive Asthma Among Rural Primary Care Providers in Southwestern China.

Authors:  Huidi Liu; Huibo Li; Dirk E Teuwen; Sean Sylvia; Haonan Shi; Scott Rozelle; Hongmei Yi
Journal:  Front Pharmacol       Date:  2022-02-15       Impact factor: 5.810

9.  Omalizumab Improves Quality of Life and Asthma Control in Chinese Patients With Moderate to Severe Asthma: A Randomized Phase III Study.

Authors:  Jing Li; Jian Kang; Changzheng Wang; Jing Yang; Linda Wang; Ioannis Kottakis; Michael Humphries; Nanshan Zhong
Journal:  Allergy Asthma Immunol Res       Date:  2016-07       Impact factor: 5.764
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.